Supramolecular Combination Cancer Therapy Based on Macrocyclic Supramolecular Materials

N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Supramolecular combination therapy adopts supramolecular materials to design intelligent drug delivery systems with different strategies for cancer treatments. Thereinto, macrocyclic supramolecular materials play a crucial role in encapsulating anticancer drugs to improve anticancer efficiency and decrease toxicity towards normal tissue by host–guest interaction. In general, chemotherapy is still common therapy for solid tumors in clinics. However, supramolecular combination therapy can overcome the limitations of the traditional single-drug chemotherapy in the laboratory findings. In this review, we summarized the combination chemotherapy, photothermal chemotherapy, and gene chemotherapy based on macrocyclic supramolecular materials. Finally, the application prospects in supramolecular combination therapy are discussed.

Cite

CITATION STYLE

APA

Li, Y., Su, Y., Li, Z., & Chen, Y. (2022, November 1). Supramolecular Combination Cancer Therapy Based on Macrocyclic Supramolecular Materials. Polymers. MDPI. https://doi.org/10.3390/polym14224855

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free